
Barbie with type 1 diabetes: Changing the narrative
In December 2023, Mattel approached Breakthrough T1D with a partnership opportunity for the first Barbie with type 1 diabetes (T1D). Less than two years later, in July 2025, Barbie with T1D was launched. The collaboration reflects our commitment to ensuring that the millions of people living with T1D are seen, heard, and empowered. Barbie with […]

Marshalls and Breakthrough T1D: Local community, global impact
As Breakthrough T1D’s largest corporate partner, Marshalls has raised more than $47 million to-date to improve and change life with type 1 diabetes.

How do school cell phone bans impact students with type 1 diabetes?
For students with type 1 diabetes who use technology to manage the condition, school cell phone bans can present challenges.

Study: Patients willing to incur risks for benefits of novel T1D therapies
A new Breakthrough T1D-funded study finds that people with T1D and their caregivers are largely willing to try advanced new T1D therapies.

School nurses have incredible impact
School nurses are essential to a child’s type 1 diabetes care. At Woodward Academy in Atlanta, GA, that person is Nurse Whyte.

Hy-Vee and Breakthrough T1D: Changing lives
Hy-Vee has been a trusted partner of Breakthrough T1D since 1988, raising nearly $20 million through corporate and store events.

Type 1 diabetes recipe box
Explore type 1 diabetes recipes that are healthy and tasty! Our recipe box includes ideas for breakfast, lunch, dinner, and even desserts!

Wawa and Breakthrough T1D: A long-standing partnership
Since 1994, Wawa has raised millions of dollars for type 1 diabetes research through in-store fundraising campaigns across the Eastern U.S.

A new Breakthrough T1D publication is paving the way for beta cell replacement therapies
Breakthrough T1D’s newest publication outlines a roadmap for beta cell replacement therapies for type 1 diabetes.

New publication alert: Engineered islets are making insulin and avoiding immune detection in first person treated
Hypoimmune (HIP) islets are making insulin, without immunosuppressants, in the first person treated with type 1 diabetes.